Challenges in the Pharmacogenomic Annotation of Whole Genomes
Next‐generation sequencing technologies have enabled the sequencing of an entire genome for less than $4,000. With access to all the genetic variation in an individual, our task will be to use this information to assess the genetic influences on drug efficacy, toxicity, and dosage. Clinical Pharmaco...
Gespeichert in:
Veröffentlicht in: | Clinical pharmacology and therapeutics 2013-08, Vol.94 (2), p.211-213 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Next‐generation sequencing technologies have enabled the sequencing of an entire genome for less than $4,000. With access to all the genetic variation in an individual, our task will be to use this information to assess the genetic influences on drug efficacy, toxicity, and dosage.
Clinical Pharmacology & Therapeutics (2013); 94 2, 211–213. doi:10.1038/clpt.2013.111 |
---|---|
ISSN: | 0009-9236 1532-6535 |
DOI: | 10.1038/clpt.2013.111 |